Salta al contenuto principale

catechol-O-methyltransferase

L COMT gene provides instructions for making an enzyme called catechol-O-methyltransferase. Two versions of this enzyme are made from the gene. The longer form, called membrane-bound catechol-O-methyltransferase (MB-COMT), is chiefly produced by nerve cells in the brain. Other tissues, including the liver, kidneys, and blood, produce a shorter form of the enzyme called soluble catechol-O-methyltransferase (S-COMT). This form of the enzyme helps control the levels of certain hormones.

Normal function

L COMT gene provides instructions for making an enzyme called catechol-O-methyltransferase. Two versions of this enzyme are made from the gene. The longer form, called membrane-bound catechol-O-methyltransferase (MB-COMT), is chiefly produced by nerve cells in the brain. Other tissues, including the liver, kidneys, and blood, produce a shorter form of the enzyme called soluble catechol-O-methyltransferase (S-COMT). This form of the enzyme helps control the levels of certain hormones.

In the brain, catechol-O-methyltransferase helps break down certain chemical messengers called neurotransmitters. These chemicals conduct signals from one nerve cell to another. Catechol-O-methyltransferase is particularly important in an area at the front of the brain called the prefrontal cortex, which organizes and coordinates information from other parts of the brain. This region is involved with personality, planning, inhibition of behaviors, abstract thinking, emotion, and working (short-term) memory. To function efficiently, the prefrontal cortex requires signaling by neurotransmitters such as dopamine and norepinephrine. Catechol-O-methyltransferase helps maintain appropriate levels of these neurotransmitters in this part of the brain.

Conditions referring to this gene or chromosome

Altri nomi

Catechol Methyltransferase

COMT_HUMAN

Related patient information and medicines

Malattia di Parkinson

Patient information leaflet

Malattia di Parkinson

Parkinson's disease is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The deficiency of dopamine leads to a movement disorder with Parkinson's disease symptoms. Sometimes these medicines are used in combination with levodopa in the later stages of PD..

Tolcapone per la malattia di Parkinson

Medicine leaflet

Tolcapone per la malattia di Parkinson

Tolcapone will be recommended for you by a specialist doctor who will continue to check on your progress. You should tell your doctor immed... About tolcapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Utilizzato per Malattia di Parkinson Also called Tasmar® Available as Tablets Parkinson's disease affects the.

Entacapone per la malattia di Parkinson

Medicine leaflet

Entacapone per la malattia di Parkinson

Entacapone will be recommended for you by a specialist doctor who will continue to check on your progress. About entacapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Used for Parkinson's disease Also called Comtess®; Combination brands: Stalevo®, Sastravi®, Stanek®, Lecigon® (entacapone with levodopa.

Tioguanine

Medicine leaflet

Tioguanine

You will be prescribed tioguanine by a doctor who specialises in cancer treatment. Tioguanine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and chronic myeloid leukaemia (CML). If you have ever been told by a doctor that you lack certain enzymes... In particular, tell your doctor if you know your.

Mercaptopurine

Medicine leaflet

Mercaptopurine

You will be prescribed mercaptopurine by a specialist cancer doctor. About mercaptopurine Type of medicine An antimetabolite anti-cancer medicine Used for Treatment of leukaemia Also called Xaluprine®; Hanixol® Available as Tabl... Mercaptopurine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 24 Mar 2026 | Ultima versione
  • 1 Sept 2007 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.